APTARGROUP, INC. (ATR) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, APTARGROUP, INC.'s filing signal turned negative.

AptarGroup designs and manufactures a wide array of drug delivery, consumer product dispensing, and protection technologies for diverse end markets including pharmaceutical, beauty, personal care, food, and beverage. The company leverages proprietary design, engineering, and materials science capabilities to deliver safe, functional, and differentiated product solutions. With a global footprint of approximately 14,000 employees across 20 countries, Aptar serves around 5,000 customers, with no single customer accounting for more than 4% of net sales. Its primary products include dispensing pumps, closures, aerosol valves, and elastomeric primary packaging components, alongside active material science and digital health solutions.

Revenue is driven by the sale of dispensing systems, sealing solutions, and closures across its Pharma, Beauty, and Closures segments. Key drivers include product volume growth, tooling sales, and royalty income, particularly within the Pharma segment's prescription drug and injectables markets.